[HARTA] YoY TTM Result on 31-Dec-2019 [#3]

Stock
[HARTA] HARTALEGA HOLDINGS BHD
Announcement Date
11-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2020
Quarter
31-Dec-2019 [#3]
Profit Trend
QoQ- 0.37%
YoY- -14.73%
Quarter Report
Latest QR
Upcoming QR
HARTA's Result
HARTA's Financial Summary
View:
Show?
TTM Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 2,860,765 9,219,451 5,173,902 2,829,964 2,760,831 2,315,794 1,695,543 9.10%
PBT 359,119 5,930,627 2,439,228 532,358 573,158 510,343 300,927 2.98%
Tax -459,637 -1,373,198 -544,932 -120,823 -91,455 -97,614 -45,421 47.04%
NP -100,518 4,557,429 1,894,296 411,535 481,703 412,729 255,506 -
-
NP to SH -113,190 4,551,698 1,881,896 410,563 481,490 412,176 255,167 -
-
Tax Rate 127.99% 23.15% 22.34% 22.70% 15.96% 19.13% 15.09% -
Total Cost 2,961,283 4,662,022 3,279,606 2,418,429 2,279,128 1,903,065 1,440,037 12.76%
-
Net Worth 4,955,320 5,810,669 4,169,311 2,455,939 2,194,080 1,930,255 1,617,360 20.50%
Dividend
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Div 239,237 2,989,309 600,186 247,826 285,279 197,436 131,364 10.50%
Div Payout % 0.00% 65.67% 31.89% 60.36% 59.25% 47.90% 51.48% -
Equity
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Net Worth 4,955,320 5,810,669 4,169,311 2,455,939 2,194,080 1,930,255 1,617,360 20.50%
NOSH 3,427,606 3,427,606 3,427,606 3,373,095 3,330,525 1,652,132 1,643,324 13.02%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -3.51% 49.43% 36.61% 14.54% 17.45% 17.82% 15.07% -
ROE -2.28% 78.33% 45.14% 16.72% 21.94% 21.35% 15.78% -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 83.71 269.73 151.40 84.12 83.05 140.37 103.18 -3.42%
EPS -3.31 133.17 55.07 12.20 14.48 24.98 15.53 -
DPS 7.00 87.45 17.65 7.40 8.60 12.00 8.00 -2.19%
NAPS 1.45 1.70 1.22 0.73 0.66 1.17 0.9842 6.66%
Adjusted Per Share Value based on latest NOSH - 3,373,095
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 83.46 268.98 150.95 82.56 80.55 67.56 49.47 9.10%
EPS -3.30 132.80 54.90 11.98 14.05 12.03 7.44 -
DPS 6.98 87.21 17.51 7.23 8.32 5.76 3.83 10.51%
NAPS 1.4457 1.6953 1.2164 0.7165 0.6401 0.5631 0.4719 20.50%
Price Multiplier on Financial Quarter End Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 -
Price 1.70 5.73 12.14 5.48 6.14 10.68 4.83 -
P/RPS 2.03 2.12 8.02 6.51 7.39 7.61 4.68 -12.98%
P/EPS -51.33 4.30 22.05 44.91 42.39 42.75 31.11 -
EY -1.95 23.24 4.54 2.23 2.36 2.34 3.21 -
DY 4.12 15.26 1.45 1.35 1.40 1.12 1.66 16.35%
P/NAPS 1.17 3.37 9.95 7.51 9.30 9.13 4.91 -21.25%
Price Multiplier on Announcement Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 07/02/23 08/02/22 25/01/21 11/02/20 12/02/19 06/02/18 14/02/17 -
Price 1.58 5.57 13.00 6.00 5.45 10.84 4.75 -
P/RPS 1.89 2.07 8.59 7.13 6.56 7.72 4.60 -13.77%
P/EPS -47.70 4.18 23.61 49.17 37.63 43.39 30.59 -
EY -2.10 23.91 4.24 2.03 2.66 2.30 3.27 -
DY 4.43 15.70 1.36 1.23 1.58 1.11 1.68 17.53%
P/NAPS 1.09 3.28 10.66 8.22 8.26 9.26 4.83 -21.96%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment